Company news
Cyclerion Therapeutics, Inc. news in 2026
Cyclerion Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement
March 31, 2026
Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
February 17, 2026
Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression
January 5, 2026
Decks in 2026
- Korsana Biosciences — Merger or Acquisition (July 2026)
Merger or acquisition · 32 slides · July 2026
- Merger or Acquisition (April 2026)
Merger or acquisition · 52 slides · Apr 1, 2026
- Merger or Acquisition (April 2026)
Merger or acquisition · 56 slides · Apr 1, 2026
- Korsana Biosciences — Merger or Acquisition (April 2026)
Merger or acquisition · 31 slides · April 2026
- Korsana Biosciences — Investor Presentation (February 2026)
Investor deck · 28 slides · February 2026
- Investor Presentation (January 2026)
Investor deck · 28 slides · Jan 6, 2026